Renal cell carcinoma (RCC) is the leading cause among cancer-related deaths due to urological cancers, which results in response to combination of genetic and epigenetic factors. Histone methylations have been implicated in renal tumorigenesis but their clinical significance and underlying pathology are unexplored. Here, we elucidated the histone 3 lysine 4 (H3K4) methylation patterns in clear cell RCC and its underlying pathology. Lower cellular levels of H3K4 mono-methylation, -dimethylation and -tri-methylation were fraternized with higher TNM staging and Fuhrman grading as well as tumor metastasis. Further, the expression profile of 20 H3K4 modifiers revealed the significant over-expression of histone demethylases compared to methyltransferases, indicating their role in the reduction of H3K4 methylation levels. In view of above facts, the role of LSD2 and KDM5A demethylases in RCC pathogenesis were explored using respective siRNAs. The RCC cells exhibited reduced cell viability after knockdown of LSD2 and KDM5A genes with concomitant induction of apoptosis. In addition, propidium iodide staining demonstrated an arrest of RCC cells at S-phase and sub-G1 phase of the cell cycle. Taken together, these observations provide new pathological insights behind the alterations of H3K4 methylation patterns in ccRCC with their prognostic and therapeutic implications.
Scientific reports. 2019 Jun 03*** epublish ***
Aman Kumar, Niti Kumari, Ujjawal Sharma, Sant Ram, Shrawan Kumar Singh, Nandita Kakkar, Karanvir Kaushal, Rajendra Prasad
Department of Biochemistry, Post Graduate Institute of Medical Educational and Research, Chandigarh, India., Department of Urology, Post Graduate Institute of Medical Educational and Research, Chandigarh, India., Department of Histopathology, Post Graduate Institute of Medical Educational and Research, Chandigarh, India., Department of Biochemistry, Post Graduate Institute of Medical Educational and Research, Chandigarh, India. .